Acalabrutinib M7 Metabolite - Request Quote
Acalabrutinib M7 Metabolite
| SZ CAT No: | SZ-A078007 |
| CAS No | NA |
| Mol.F. | C31H33N9O5S |
| Mol.Wt. | 643.7 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Acalabrutinib M7 Metabolite is chemically S-((Z)-4-((S)-2-(8-amino-1-(4-(pyridin-2-ylcarbamoyl)phenyl)imidazo[1,5-a]pyrazin-3-yl)pyrrolidin-1-yl)-4-oxobut-2-en-2-yl)-D-cysteinylglycine. Acalabrutinib M7 Metabolite is supplied with detailed characterization data compliant with regulatory guideline. Acalabrutinib M7 Metabolite can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Acalabrutinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Acalabrutinib M7 Metabolite
Purchase Acalabrutinib M7 Metabolite
Acalabrutinib M7 Metabolite suppliers
Acalabrutinib M7 Metabolite manufacturers
Acalabrutinib M7 Metabolite price
Order Acalabrutinib M7 Metabolite
Enquire Acalabrutinib M7 Metabolite
Acalabrutinib M7 Metabolite cost
Acalabrutinib M7 Metabolite Supplier
Acalabrutinib M7 Metabolite Distributor
Acalabrutinib M7 Metabolite for Method Validation
Acalabrutinib Reference Standard
Acalabrutinib M7 Metabolite for ANDA Filing
Acalabrutinib M7 Metabolite for Forced Degradation Studies
Acalabrutinib M7 Metabolite Identification Standards
Acalabrutinib M7 Metabolite for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


